- PMID 25647404. S2CID 586699. "
RhoGAM product label,
includes clinical trial data and
prescribing information" (PDF).
rhogam.com. "History of HDN Treatment"...
- of anti-
Rho(D)
immune globulin (Rhoclone,
Rhogam, AntiD). With
successful mitigation of this
disease by
prevention through the use of anti-
Rho(D) immune...
- kernicterus,
hydrops fetalis, and
intrauterine fetal demise. RhD
immune globulin (
RhoGam) is
administered to
prevent maternal Rh
sensitization in Rh
negative patients...
-
devices and
neurosurgery technologies. In 1968, the
company developed the
RhoGAM vaccine. The
vaccine prevented Rh
hemolytic disease in newborns. In 1969...
-
erythroblastosis fetalis.
Pollack co-developed the vaccine, also
known by the
RhoGAM brand name,
which is
given to
pregnant women to
prevent Rh disease, with...
- as an anti-D immunoglobulin,
called RhoGAM, will be
given to the RhD- mother.
Injecting RhD-
mother with
RhoGAM has been
proven effective in avoiding...
-
until the mid-1970s and 1985, respectively. In 1968,
Ortho introduced RhoGAM Rho(D)
immune globulin, the
first medication developed to
prevent Rh hemolytic...
- HDN.
Since the
introduction of
Rho-D immunoglobulin, (
Rhogam, at 1968,
which prevents the
production of
maternal Rho-D antibodies, the
incidence of anti-D...
- risk of infection. In
cases where the
woman is Rh-negative,
Rho(D)
immunoglobulin (
RhoGam) is
administered to
prevent the risk of
developing erythroblastosis...
- However, the
rates of
these cases have been
significantly reduced by RhIg (
RhoGam) administration.
Measures are not
available for
preventing alloimmunization...
